Trials / Completed
CompletedNCT00002019
Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Liposome · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety, tolerance and efficacy of three different dosage regimens of Amphotericin B Lipid Complex (ABLC) compared to Fungizone (Amphotericin B) in patients with AIDS and cryptococcal meningitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amphotericin B, Lipid-based | |
| DRUG | Amphotericin B |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002019. Inclusion in this directory is not an endorsement.